Nexus - 1402 - New Times Magazine-pages

Page Content (OCR)

NEWSCIENCENEWSCIENCENEWSCIENCE of chicken legs gives 50 grams of Revital. to provide any evidence of contamination. answer is that the mice had an incomplete In 1977, Dr Robertson began to sell At Dr Robertson's request, several immune defence system. In order to products which he had made himself. He random samples of Revital were sent to achieve regeneration, the chicken leg applied to the US Food and Drug four different independent laboratories, and extract must be from immunologically Administration (FDA) for permission to all reported that the product satisfied immature chickens, i.e., less than nine market Revital as a "Class I device" (baby _ sterility requirements of the United States | weeks old. How does chicken leg extract powder also belongs to this group) and this Pharmacopeia (UPS). (Note: preparations from immunologically immature chickens was allowed without prescription since it of Revital have a typical pH of ~4.6, differ from that from immunologically contained no physically damaging which, to say the least, is not ideal for the mature chickens? Nobody knows, but it substances. The sales of Revital in the growth of bacteria!) should be possible to find out. It is local pharmacy rose to US$39,000 per However, the FDA was determined to possible that a tissue extract from month from word-of-mouth advertising, immunologically immature animals has the and in addition there were postal sales. ability to transform human skin cells The June 1981 issue of Science Digest . . (which are easy to grow) to stem cells, published a four-page article about Dr It Is possible that solving the problem of how to produce Robertson. In the same year, the FDA a tissue extract from large amounts of stem cells. ©0 asked Dr Robertson to register Revital as . . . a drug—a process which could take up immunologically immature Endnotes to 10 years and cost millions of dollars, animals has the ability * Desquenne-Clark, L., Clark, R., Heber- but with the aid of lawyers he was able Hy Katz, E. (1998), "A new model for mam- to retain the "Class I device" to transform human skin malian wound repair and regeneration", designation. Clin. Imm. and Immunopath. 88:35-45. Subsequently, the FDA reported that cells to stem cells... + Heber-Katz, E. (1999), "The regenerating Revital contained high levels of bacteria mouse ear", Seminars in Cell and and did not comply with its Developmental Biology 10(4):415-420. requirements. Dr Robertson was therefore prevent the sale of Revital in the "country Leferovich, J., Bedelbaeva, K., forbidden to market his products. of free enterprise", and Dr Robertson was Samuelewicz, S., Xhang, X.-M., Zwas, D. warned not to attempt to reintroduce his _ R., Lankford, E. B. and Heber-Katz, E. FDA stops Dr Robertson and Revital product. He was now nearly 80 years old (2001), "Heart regeneration in adult MRL Like SS stormtroopers, FDA agents and too disheartened to try to market mice", Proc. National Academy of Sciences raided the John L. Deaton Medical Center Revital in another country. USA 98(17):9830-35. in Baltimore and confiscated all Revital Thus did the FDA succeed in killing off + Seitz, A., Aglow, E. and Heber-Katz, E. products in the ward where patients with _ this miracle remedy. (2002), "Recovery from spinal cord injury: chronic bedsores were being treated. The A new transection model in the C57B1/6 FDA was required by the Freedom of Relationship between experiments mouse", J. Neuroscience Research Information Act to produce the results of What is the connection between Dr _67(3):337-45. its sterility tests on the three random Robertson's Revital discovery and Dr __« The information on Dr Harry Robertson is samples they had examined, but was unable Heber-Katz's experiments on mice? The _ taken from the article "Curative Protein of Chicken Feet", pp. 185-187, in the com- pendium Creative Alternatives for a Troubled World, © 1993 Melvin D. a —_ — ee, Po a Saunders, Pyramid Research Center, Box a 478, Odenton, Maryland 21113, USA. Bopy PARTS * The transcript of Harry J. Robertson's US P' y EGEMERAT On| Patent No. 4,455,302, "Medical protein LAB > (GIA IE fos hydrolysate, process of making the same and processes of utilizing the protein hydrolysate to aid in healing traumatised areas", can be found at http://www.uspto.gov/. to provide any evidence of contamination. At Dr Robertson's request, several random samples of Revital were sent to four different independent laboratories, and all reported that the product satisfied sterility requirements of the United States Pharmacopeia (UPS). (Note: preparations of Revital have a typical pH of ~4.6, which, to say the least, is not ideal for the growth of bacteria!) However, the FDA was determined to immunologically immature animals has the ability to transform human skin FDA stops Dr Robertson and Revital Like SS stormtroopers, FDA agents raided the John L. Deaton Medical Center in Baltimore and confiscated all Revital products in the ward where patients with chronic bedsores were being treated. The FDA was required by the Freedom of Information Act to produce the results of its sterility tests on the three random samples they had examined, but was unable Relationship between experiments What is the connection between Dr Robertson's Revital discovery and Dr Heber-Katz's experiments on mice? The About the Author: Bengt Larsson, MSc, has always been interested in revolutionary discoveries and inventions and is looking forward to the day when complete regeneration of human body parts is accomplished. Presently he is working as a senior high- school teacher in Vaxjo, Sweden. He can be contacted by email at bengt_ larsson@kungsmadskolan.se. 50 + NEXUS It is possible that a tissue extract from cells to stem cells... Samar: (fe www.nexusmagazine.com FEBRUARY — MARCH 2007